Thursday, October 10, 2013
Publication and contact
Assays & screens
profiling (BCP) to identify the mechanism of action for antibacterial
BCP can help identify the mechanism of action for antibacterial compounds.
BCP distinguished between inhibitors of five major biological pathways
including translation, transcription, DNA replication, membrane synthesis and
peptidoglycan synthesis. BCP also distinguished subclasses of inhibitors
within each of the five classes. In Escherichia coli grown in the
presence of compounds at five times minimum inhibitory concentration, BCP
revealed that spirohexenolide A-a compound with an
unknown mechanism of action-caused a collapse in proton motive force and
induced a phenotype similar to that initiated by the antibacterial peptide nisin.
Next steps include using BCP to screen for new antibacterial compounds and
developing BCP for use in other pathogens.
Published online Oct. 10, 2013
Patent application filed;
licensed to Linnaeus Bioscience Inc.
Nonejuie, P. et al.
Proc. Natl. Acad. Sci. USA; published online
Sept. 17, 2013;
Contact: Joe Pogliano, University of California, San Diego,
La Jolla, Calif.
All contents Copyright © 1993-2017 BioCentury Publications, Inc. ALL RIGHTS RESERVED. All use of this Web Site and its contents is governed by the BioCentury User Agreement
. The contents of this Web Site are protected under U.S. and foreign copyright and intellectual property laws, and no part of this Web Site or its contents may be photocopied, reproduced or retransmitted in any form without the written consent of BioCentury, which may be requested from Reprints/Permissions
. BioCentury®; The Bernstein Report on BioBusiness™; The BioCentury 100™; The Clear Route to ROI™; Because Real Intelligence is Hard to Find™; BCIQ™; and BioPharma's Knowledge Center™; are trademarks of BioCentury Publications, Inc., P.O. Box 1246, San Carlos, CA 94070. SciBX® and SciBX: Science-Business eXchange® are trademarks of Nature America, Inc. that are jointly used by BioCentury Publications, Inc. and Nature America, Inc.
Thanks for purchasing this article.
Please bookmark this url for future reference.
We have also sent you a confirming e-mail with a receipt and this same url for your
close [ X ]